VNDA Vanda Pharmaceuticals Inc.
Healthcare$6.22+0.48%ClosedMarket Cap: $374.0M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
1
Buy/Sell Ratio
1.00
Net Shares
+31,265
Shares Acquired
57,101
Shares Disposed
25,836
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 20 | Mitchell Stephen Ray | director | Sell | 25,836 | $0.00 | 71,246 |
| Fri Apr 24 | Duncan Charles Cliff | director | Sell | 57,101 | $0.00 | 57,101 |
| Fri Apr 24 | Duncan Charles Cliff | Sell | 0 | $0.00 | 0 | |
| Mon Apr 13 | Polymeropoulos Christos Vasilios Mihael | officer: Senior VP, Medical Director | Sell | 61,200 | $7.05 | 0 |
| Mon Apr 13 | Polymeropoulos Christos Vasilios Mihael | officer: Senior VP, Medical Director | Sell | 0 | $0.00 | 129,791 |
| Mon Apr 13 | Howell Scott Laverne | officer: VP and Chief People Officer | Sell | 0 | $0.00 | 100,000 |
| Wed Mar 04 | Williams Timothy | officer: SVP & General Counsel | Sell | 42,434 | $8.27 | 377,450 |
| Wed Mar 04 | Wijkstrom Joakim | officer: SVP, Chief Marketing Officer | Sell | 30,800 | $8.27 | 333,469 |
| Wed Mar 04 | Polymeropoulos Mihael Hristos | director, officer, other: President and CEO | Sell | 156,235 | $8.17 | 2,704,496 |
| Wed Mar 04 | Moran Kevin Patrick | officer: SVP, CFO & Treasurer | Sell | 42,442 | $8.27 | 411,380 |
| Wed Mar 04 | Birznieks Gunther | officer: SVP, Business Development | Sell | 42,431 | $8.27 | 494,197 |
| Tue Feb 24 | Honore Tage | director | Sell | 30,000 | $8.03 | 93,469 |
| Thu Feb 19 | Williams Timothy | officer: SVP & General Counsel | Sell | 125,000 | $0.00 | 419,884 |
| Thu Feb 19 | Wijkstrom Joakim | officer: SVP, Chief Marketing Officer | Sell | 125,000 | $0.00 | 364,269 |
| Thu Feb 19 | Moran Kevin Patrick | officer: SVP, CFO & Treasurer | Sell | 125,000 | $0.00 | 453,822 |